[ENZ] Enzo Biochem, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical Specialities

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 6.9 Change: 0.05 (0.73%)
Ext. hours: Change: 0 (0%)

chart ENZ

Refresh chart

Strongest Trends Summary For ENZ

ENZ is in the medium-term up 22% in 1 month and down -32% in 5 months and down -51% in 1 year. In the long-term down -76% below S&P in 2 years and down -98% below S&P in 27 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Enzo Biochem, Inc., an integrated life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory in Farmingdale, New York; a network of approximately 35 patient service centers in New York and New Jersey; and a standalone laboratory in the New York, as well as a full-service phlebotomy, in-house logistics department, and information technology department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug developmen

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -3.7% Sales Growth - Q/Q3.87% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-23.75% ROE-40.8% ROI
Current Ratio1.6 Quick Ratio1.25 Long Term Debt/Equity Debt Ratio0.66
Gross Margin43.84% Operating Margin-13.29% Net Profit Margin-14.35% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities6.37 M Cash From Investing Activities-1.17 M Cash From Operating Activities-8.17 M Gross Profit10.48 M
Net Profit-2.91 M Operating Profit-2.85 M Total Assets58.52 M Total Current Assets36.06 M
Total Current Liabilities22.54 M Total Debt3.41 M Total Liabilities24.46 M Total Revenue23.99 M
Technical Data
High 52 week8.41 Low 52 week2.46 Last close2.96 Last change-1.99%
RSI64.13 Average true range0.17 Beta1.6 Volume42.07 K
Simple moving average 20 days6.69% Simple moving average 50 days-2.75% Simple moving average 200 days-35.78%
Performance Data
Performance Week5.71% Performance Month-8.36% Performance Quart-25.06% Performance Half-42.41%
Performance Year-63.59% Performance Year-to-date6.47% Volatility daily3.55% Volatility weekly7.93%
Volatility monthly16.26% Volatility yearly56.31% Relative Volume117.6% Average Volume204.43 K
New High New Low

News

2019-01-02 13:40:08 | How Many Insiders Bought Enzo Biochem, Inc. NYSE:ENZ Shares?

2018-12-17 18:57:48 | Edited Transcript of ENZ earnings conference call or presentation 11-Dec-18 1:30pm GMT

2018-12-10 16:21:31 | Enzo Biochem: Fiscal 1Q Earnings Snapshot

2018-12-10 16:15:00 | Enzo Biochem Reports Fiscal 2019 First Quarter Results

2018-12-06 09:00:00 | Enzo Biochem Schedules Teleconference to Discuss First Quarter 2019 Results Tuesday, December 11, 2018 at 8:30 AM E.T.

2018-12-03 09:00:00 | Enzo Biochem Reports Publication of Study on Therapeutic Candidate SK1-I Detailing Promising Results in a Model of Treatment-Resistant Breast Cancer

2018-11-14 12:57:36 | What Kind Of Shareholder Owns Most Enzo Biochem Inc NYSE:ENZ Stock?

2018-10-29 08:25:00 | Market Trends Toward New Normal in Polaris Industries, NIKE, Charles River Laboratories International, Actuant, Caesarstone, and Enzo Biochem — Emerging Consolidated Expectations, Analyst Ratings

2018-10-17 08:15:53 | The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise

2018-10-16 21:42:52 | Edited Transcript of ENZ earnings conference call or presentation 16-Oct-18 12:30pm GMT

2018-10-16 08:52:07 | The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist

2018-10-16 06:30:00 | Enzo Biochem, Inc. to Host Earnings Call

2018-10-15 16:20:31 | Enzo Biochem: Fiscal 4Q Earnings Snapshot

2018-10-15 16:05:00 | Enzo Biochem Reports Fourth Quarter and Fiscal 2018 Results

2018-10-11 12:49:00 | Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal 2018 Results Tuesday, October 16, 2018 at 8:30 AM E.T.

2018-10-03 19:33:00 | Top 5 Biotech Stocks for 2018

2018-09-05 18:50:00 | Top 5 Biotech Stocks for 2018

2018-08-27 08:30:00 | Enzo Biochem to Acquire New Facility for Manufacturing and Distribution to Advance Its Diagnostic and Therapeutic Growth Strategy

2018-08-02 08:15:00 | Market Trends Toward New Normal in Sandy Spring, Tupperware Brands, Dolby Laboratories, AeroVironment, Barnes Group, and Enzo Biochem — Emerging Consolidated Expectations, Analyst Ratings

2018-07-18 09:00:00 | Enzo Biochem Reports Validation of Three High Quality, Low Cost Biomarkers for Detecting Cancers and Their Progression, Especially in Women’s Health Area

2018-07-11 19:05:00 | Top 5 Biotech Stocks for 2018

2018-07-06 07:10:00 | Blog Exposure - Bruker Buys Dutch Milk Analysis Equipment Manufacturer Lactotronic to Expand its Presence in the Dairy Industry

2018-06-12 18:13:22 | Edited Transcript of ENZ earnings conference call or presentation 12-Jun-18 12:30pm GMT

2018-06-12 08:47:30 | Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate

2018-06-11 16:21:32 | Enzo Biochem: Fiscal 3Q Earnings Snapshot

2018-06-11 16:10:00 | Enzo Biochem Reports Third Quarter Results

2018-06-06 10:00:00 | Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2018 Results Tuesday, June 12, 2018 at 8:30 AM E.T.

2018-05-03 13:58:00 | Top 5 Biotech Stocks for 2018

2018-04-24 10:00:00 | Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent Involved in Delaware Infringement Case

2018-04-04 11:08:00 | Top 5 Biotech Stocks for 2018

2018-03-14 03:58:54 | Edited Transcript of ENZ earnings conference call or presentation 13-Mar-18 12:30pm GMT

2018-03-13 08:04:05 | Earnings Outlook For Enzo Biochem

2018-03-13 06:45:00 | Enzo Biochem, Inc. to Host Earnings Call

2018-03-12 16:29:15 | Enzo Biochem reports 2Q loss

2018-03-12 16:05:00 | Enzo Biochem Reports Second Quarter and First Half Results

2018-03-10 11:00:00 | Top 5 Biotech Stocks for 2018

2018-03-08 16:10:00 | Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2018 Results Tuesday, March 13, 2018 at 8:30 AM E.T.

2018-02-26 07:30:00 | Exploring Fundamental Drivers Behind Enzo Biochem, RPX, The Hackett Group, 2U, AK Steel Holding, and Och-Ziff Capital Management Group — New Horizons, Emerging Trends, and Upcoming Developments

2018-02-03 09:20:00 | Top 5 Biotech Stocks for 2018

2018-01-22 09:00:00 | Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test

2018-01-09 07:00:00 | Free Post Earnings Research Report: Enzo Biochem’s Revenue Grew 5%; Net Loss Narrowed

2018-01-05 19:20:00 | Top 5 Biotech Stocks for 2018

2017-12-19 07:50:00 | Report: Exploring Fundamental Drivers Behind Allstate, Ashford Hospitality Prime, S&P Global, Enzo Biochem, Seres Therapeutics, and HFF — New Horizons, Emerging Trends, and Upcoming Developments

2017-12-13 07:00:00 | Blog Exposure - Cancer Genetics Announces Best Diagnostic Modality to Evaluate PD-L1 in Diffuse Large B-Cell Lymphomas

2017-12-11 14:46:17 | Enzo Biochem ENZ Q1 2018 Earnings Conference Call Transcript

2017-12-11 10:40:34 | Enzo Biochem, Inc. :ENZ-US: Earnings Analysis: Q1, 2018 By the Numbers : December 11, 2017

2017-12-08 17:36:43 | Edited Transcript of ENZ earnings conference call or presentation 8-Dec-17 1:30pm GMT

2017-12-08 07:00:00 | Enzo Biochem, Inc. to Host Earnings Call

2017-12-07 16:15:44 | Enzo Biochem reports 1Q loss

2017-12-07 16:10:00 | Enzo Biochem Reports Improved First Quarter Results